Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA)

被引:15
作者
Ali, Jaber Haj [1 ,2 ]
Walter, Michael [2 ]
机构
[1] Charite Univ Med Berlin, Inst Lab Med Clin Chem & Pathobiochemi, Augustenburger Pl 1, D-13353 Berlin, Germany
[2] Univ Med Rostock, Inst Clin Chem & Lab Med, Ernst Heydemann Str 6, D-18057 Rostock, Germany
关键词
Telomerase; Cancer therapy; Cancer; TICCA; Telomere; Transient immediate complete and combinatory attack; REVERSE-TRANSCRIPTASE HTERT; CATALYTIC SUBUNIT HTERT; TERT PROMOTER MUTATIONS; HUMAN TUMOR-CELLS; G-QUADRUPLEX DNA; PEPTIDE VACCINATION; PLATINUM(II) COMPLEXES; GENE-EXPRESSION; DOWN-REGULATION; RNA GENE;
D O I
10.1186/s12935-023-03041-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomerase can overcome replicative senescence by elongation of telomeres but is also a specific element in most cancer cells. It is expressed more vastly than any other tumor marker. Telomerase as a tumor target inducing replicative immortality can be overcome by only one other mechanism: alternative lengthening of telomeres (ALT). This limits the probability to develop resistance to treatments. Moreover, telomerase inhibition offers some degree of specificity with a low risk of toxicity in normal cells. Nevertheless, only one telomerase antagonist reached late preclinical studies. The underlying causes, the pitfalls of telomerase-based therapies, and future chances based on recent technical advancements are summarized in this review. Based on new findings and approaches, we propose a concept how long-term survival in telomerase-based cancer therapies can be significantly improved: the TICCA (Transient Immediate Complete and Combinatory Attack) strategy.
引用
收藏
页数:24
相关论文
共 281 条
[1]   The Small Molecule BIBR1532 Exerts Potential Anti-cancer Activities in Preclinical Models of Feline Oral Squamous Cell Carcinoma Through Inhibition of Telomerase Activity and Down-Regulation of TERT [J].
Altamura, Gennaro ;
degli Uberti, Barbara ;
Galiero, Giorgio ;
De Luca, Giovanna ;
Power, Karen ;
Licenziato, Luca ;
Maiolino, Paola ;
Borzacchiello, Giuseppe .
FRONTIERS IN VETERINARY SCIENCE, 2021, 7
[2]   G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells [J].
Amato, Roberta ;
Valenzuela, Martina ;
Berardinelli, Francesco ;
Salvati, Erica ;
Maresca, Carmen ;
Leone, Stefano ;
Antoccia, Antonio ;
Sgura, Antonella .
GENES, 2020, 11 (03)
[3]  
Andtbacka RH, 2014, J IMMUNOTHER CANC S3, V2, pP263, DOI DOI 10.1186/2051-1426-2-S3-P263
[4]   Therapeutic Assessment of Targeting ASNS Combined with L-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms [J].
Apfel, Verena ;
Begue, Damien ;
Cordo', Valentina ;
Holzer, Laura ;
Martinuzzi, Laetitia ;
Buhles, Alexandra ;
Kerr, Grainne ;
Barbosa, Ines ;
Naumann, Ulrike ;
Piquet, Michelle ;
Ruddy, David ;
Weiss, Andreas ;
Ferretti, Stephane ;
Almeida, Reinaldo ;
Bonenfant, Debora ;
Tordella, Luca ;
Galli, Giorgio G. .
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (01) :327-337
[5]   RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells [J].
Arora, Rajika ;
Lee, Yongwoo ;
Wischnewski, Harry ;
Brun, Catherine M. ;
Schwarz, Tobias ;
Azzalin, Claus M. .
NATURE COMMUNICATIONS, 2014, 5
[6]   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [J].
Artandi, SE ;
Chang, S ;
Lee, SL ;
Alson, S ;
Gottlieb, GJ ;
Chin, L ;
DePinho, RA .
NATURE, 2000, 406 (6796) :641-645
[7]   Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters [J].
Atkinson, SP ;
Hoare, SF ;
Glasspool, RM ;
Keith, WN .
CANCER RESEARCH, 2005, 65 (17) :7585-7590
[8]   Effects of telomerase inhibitor on epigenetic chromatin modification enzymes in malignancies [J].
Avci, Cigir Biray ;
Dogan, Fatma ;
Ay, Neslihan Pinar Ozates ;
Bagca, Bakiye Goker ;
Abbaszadeh, Zeka ;
Gunduz, Cumhur .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (12) :9817-9824
[9]   Targeting telomerase for its advent in cancer therapeutics [J].
Bajaj, Shalini ;
Kumar, Maushmi S. ;
Peters, G. J. ;
Mayur, Y. C. .
MEDICINAL RESEARCH REVIEWS, 2020, 40 (05) :1871-1919
[10]   Inhibition of telomerase by BIBR 1532 and related analogues [J].
Barma, DK ;
Elayadi, A ;
Falck, JR ;
Corey, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (07) :1333-1336